Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Administration of wild sage metabolites (450 mg/day) for 30 days significantly reduced snoring and stress, decreased PSQI global score by 29%, and increased alpha brain waves by 55% [PMID:35386141]
Daily administration (10 and 25 mg/kg) alleviated colitis symptoms, reduced colonic damage, and decreased pro-inflammatory cytokines [PMID:38136191]
Essential oils from wild and cultivated S. verbenaca inhibited growth and induced apoptosis in human melanoma cell line M14 [PMID:25537231]
Essential oil exhibited growth inhibition of Gram + bacteria [PMID:21834249]
Synthèse des preuves
Sources PubMed
- 1.PMID: 35655480 (2022) — Phytochemistry and Biological Properties of Salvia verbenaca L.: A Comprehensive Review. · BioMed research international
- 2.PMID: 33000487 (2020) — In vitro antioxidant, anticholinesterases, anti-α-amylase, and anti-α-glucosidase effects of Algerian Salvia aegyptiaca and Salvia verbenaca. · Journal of food biochemistry
- 3.PMID: 38136191 (2023) — The Antioxidant Properties of Salvia verbenaca Extract Contribute to Its Intestinal Antiinflammatory Effects in Experimental Colitis in Rats. · Antioxidants (Basel, Switzerland)
- 4.PMID: 37258476 (2023) — Ultra-High-Performance Liquid Chromatography with Photodiode Array and High-Resolution Time-of-Flight Mass Spectrometry Detectors (UHPLC-PDA-ESI-ToF/HRMS) for the Tentative Structural Characterization of Bioactive Compounds of Salvia verbenaca Extracts in Relation to Their Biological Activities. · Frontiers in bioscience (Landmark edition)
- 5.